Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients

NCT01969721 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: fluticasone propionate
DRUG: salmeterol
DRUG: placebo
DRUG: placebo
DRUG: tiotropium
DRUG: olodaterol
DRUG: olodaterol
DRUG: placebo
DRUG: placebo
DRUG: tiotropium
DRUG: fluticasone propionate
DRUG: salmeterol

Sponsor

Boehringer Ingelheim